An official website of the United States government
Search Results
Search Results
April2025
S
M
T
W
R
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
April2025
S
M
T
W
R
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
All
Journals
Podcasts
topic
audience
Results returned for MBL deficiencyfrom all of CDC.gov
Emerging Infectious Disease journal ISSN: 1080-6059. Volume 17, Number 12—December 2011. Research. A Pilot Study of Host Genetic Variants Associated with Influenza-associated Deaths among Children and Young Adults1. On This Page. Figures.…Read more
Antimicrobial Resistance Laboratory Network Testing
Last Updated: Nov 2024
A summary of antibiotic resistance testing offered through CDC’s AR Lab Network.Read more
Emerging Infectious Disease journal ISSN: 1080-6059. Volume 17, Number 10—October 2011. Perspective. Global Spread of Carbapenemase-producing Enterobacteriaceae. On This Page. Figures. Figure 1 Figure 2 Figure 3 Figure 4 Figure 5.…Read more
Among the CD4 T cell subsets, the low frequency of follicular T helper cells are particularly conspicuous, yet again consistent with chronic B cell depletion. The patient also has a dysfunction in the activation of the complement system…Read more
Circovirus Hepatitis in Immunocompromised Patient, Switzerland 2140 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 30, No. 10, October 2024 DISPATCHES Circoviruses are an emerging group of DNA viruses with largely unknown pathogenicity…Read more
Emerging Infectious Disease journal ISSN: 1080-6059. Volume 30, Number 2—February 2024. Research. Rapid Detection of Ceftazidime/Avibactam Susceptibility/Resistance in Enterobacterales by Rapid CAZ/AVI NP Test. On This Page. Figures.…Read more
Ceftazidime/avibactam (CAZ/AVI), approved for clinical use in 2015, is among the latest genera- tion of commercialized antimicrobial drugs offering a valuable feature of being active against many types of carbapenem-resistant, gram-negative…Read more
Rapid Detection of Ceftazidime/Avibactam Susceptibility/Resistance in Enterobacterales by Rapid CAZ/AVI NP Test Ceftazidime/avibactam (CAZ/AVI), approved for clinical use in 2015, is among the latest genera- tion of commercialized…Read more
User’s Manual: Laboratory Assessment of Antibiotic Resistance Testing Capacity (LAARC) CS320242-A Division of Healthcare Quality Promotion Laboratory Assessment of Antibiotic Resistance Testing Capacity User’s Guide and Questionnaire…Read more
[PDF]2006-100 Chronic Lymphocytic Leukemia Radiogenicity Research
Last Updated: May 2024
2006-100 Chronic Lymphocytic Leukemia Radiogenicity Research Report of Public Meeting to Seek Input on Gaps in Chronic Lymphocytic Leukemia (CLL) Radiogenicity Research Held July 21, 2004 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers…Read more
Please use the search area above.
Please use the search area above.
Content Credential